Literature DB >> 7495094

Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension.

C Boyer-Neumann, F Brenot, M Wolf, E Peynaud-Debayle, P Duroux, D Meyer, E Anglés-Cano, G Simonneau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7495094

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  4 in total

Review 1.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

2.  Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.

Authors:  Mona Ascha; Xuan Zhou; Youlan Rao; Omar A Minai; Adriano R Tonelli
Journal:  Cardiovasc Ther       Date:  2017-10       Impact factor: 3.023

Review 3.  Epoprostenol sodium for treatment of pulmonary arterial hypertension.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Satoshi Akagi; Toshihiro Sarashina; Kentaro Ejiri; Aya Miura; Aiko Ogawa; Hiromi Matsubara; Hiroshi Ito
Journal:  Vasc Health Risk Manag       Date:  2015-05-14

4.  Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastography.

Authors:  Mengyun Lu; Kevin P Blaine; Ann Cullinane; Courtney Hall; Alina Dulau-Florea; Junfeng Sun; Herman F Chenwi; Grace M Graninger; Bonnie Harper; Keshia Thompson; Janell Krack; Christopher F Barnett; Samuel B Brusca; Jason M Elinoff; Michael A Solomon
Journal:  Pulm Circ       Date:  2021-06-24       Impact factor: 3.017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.